CIK 0000939767 · Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043257395
- Phone
- 6508377000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-28 | WYSZOMIERSKI JACK L Director | Option exercise 10b5-1 | +15,874 | $20.50 | $325K | 365,373 |
| 2025-02-28 | WYSZOMIERSKI JACK L Director | Sale 10b5-1 | −8,768 | $37.80 | $331K | 356,605 |
| 2025-02-28 | WYSZOMIERSKI JACK L Director | Option exercise · Option (right to buy) 10b5-1 | −15,874 | 0 | ||
| 2025-02-27 | Smith Julie Director | Option exercise | +31,167 | $20.50 | $639K | 41,945 |
| 2025-02-27 | Smith Julie Director | Option exercise | +23,347 | $19.77 | $462K | 65,292 |
| 2025-02-27 | Smith Julie Director | Sale | −54,514 | $38.13 | $2.1M | 10,778 |
| 2025-02-27 | Smith Julie Director | Option exercise · Option (right to buy) | −31,167 | 0 | ||
| 2025-02-27 | Smith Julie Director | Option exercise · Option (right to buy) | −23,347 | 19,294 | ||
| 2025-02-26 | MORRISSEY MICHAEL President and CEO | Grant or award | +184,909 | 1,033,290 | ||
| 2025-02-26 | Aftab Dana CSO/EVP Disc & Trans Research | Grant or award | +49,209 | 561,117 | ||
| 2025-02-26 | Haley Patrick J. EVP, Commercial | Grant or award | +47,718 | 351,028 | ||
| 2025-02-26 | Hessekiel Jeffrey EVP & General Counsel | Grant or award | +52,192 | 597,608 | ||
| 2025-02-26 | Peterson Amy C. EVP Prod Dev & Med Aff & CMO | Grant or award | +52,192 | 347,089 | ||
| 2025-02-26 | Senner Christopher J. EVP and CFO | Grant or award | +59,648 | 839,255 | ||
| 2025-02-25 | Oliver Bob Director | Option exercise | +15,147 | $19.28 | $292K | 52,161 |
| 2025-02-25 | Oliver Bob Director | Sale | −18,647 | $37.25 | $695K | 33,514 |
| 2025-02-25 | Oliver Bob Director | Option exercise · Option (right to buy) | −15,147 | 21,206 | ||
| 2025-02-24 | Haley Patrick J. EVP, Commercial | Sale | −52,636 | $36.98 | $1.9M | 303,310 |
| 2025-02-24 | Aftab Dana CSO/EVP Disc & Trans Research | Sale | −26,987 | $36.75 | $992K | 511,908 |
| 2025-02-24 | MORRISSEY MICHAEL President and CEO | Gift | −177,985 | 848,381 |
Page 9 of 10 · 192 trades